Company CVAbout Balaxi Pharmaceuticals Ltd 
Balaxi Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942. The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017. The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India.
Company Coordinates
Company Details
41/298-D2 2nd Flr Saniya Plaza, Mahakavi Bharatiyar Road Cochin Kerala : 682035
Registrar Details
SKDC Consultants Ltd , Kanapathy Towers, 3rd Floor, Ganapathy, Coimbatore
Capital StructureCapital Structure
Present Equity Capital
INR 11.04 Cr
Number of Shares
5.52 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
30-May-2024
5.52
11.04
44166000
2
Stock Split
11-Apr-2024
1.1
11.04
61000
10
Conversion of Warrants
03-Apr-2024
1.1
10.98
82750
10
Conversion of Warrants
15-Mar-2024
1.09
10.90
150500
10
Conversion of Warrants
23-Feb-2024
1.07
10.75
413000
10
Conversion of Warrants
25-Jan-2024
1.03
10.33
104050
10
Conversion of Warrants
09-May-2023
1.02
10.23
48950
10
Preferential Issue Of Shares
14-Mar-2023
1.02
10.18
23750
10
Preferential Issue Of Shares
15-Feb-2023
1.02
10.16
16500
10
Preferential basis
27-Jan-2023
1.01
10.14
116500
10
Preferential basis
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 1 FIIs (3.5%)
Promoter with highest holding
Balaxi Overseas Private Limited (63.4%)
Highest Public shareholder
Nexpact Limited (3.5%)
Individual Investors Holdings
20.03%
Board of Directors
Management
Designation
Remuneration
Ashish Maheshwari
Chairman / Executive Director
83.0 lacs
Minoshi Maheshwari
Non Executive Director
11.5 lacs
Kunal M Bhakta
Independent Non Exe. Director
3.0 lacs
Gandhi Gamji
Independent Non Exe. Director
2.5 lacs
M. Srinivas Rao
Independent Non Exe. Director
3.0 lacs
Purnima Singh Kamble
Independent Non Exe. Director
3.0 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Stock in trade
50.9416
0%
Purchase of Stock in trade
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
56 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
Pharmaceuticals & Biotechnology
INR Cr (Micro Cap)
13.00
NA
0.00%
0.00
0.00%
0.00
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
